https://scholars.lib.ntu.edu.tw/handle/123456789/533870
標題: | 2018 expert consensus on the management of adverse effects of antiplatelet therapy for acute coronary syndrome in Taiwan | 作者: | Li Y.-H. Fang C.-Y. Hsieh I.-C. Huang W.-C. Lin T.-H. Sung S.-H. Chiu C.-Z. Wu C.-J. Shyu K.-G. PO-YUAN CHANG Fang C.-C. Lu T.-M. Chen C.-P. Tai W.-C. Sheu C.-C. Wei K.-C. Huang Y.-H. Wu H.-M. HWANG, JUEY-JEN |
公開日期: | 2018 | 出版社: | Republic of China Society of Cardiology | 卷: | 34 | 期: | 3 | 起(迄)頁: | 201-210 | 來源出版物: | Acta Cardiologica Sinica | 摘要: | Antiplatelet therapy is a key component in the treatment of acute coronary syndrome (ACS). The management of ACS has evolved considerably over recent years with the development of new and more potent antiplatelet agents. Clinical trials on ACS have demonstrated that potent antiplatelet agents can more effectively reduce cardiovascular events. However, there is a tipping point between safety and efficacy, beyond which the risk of bleeding and other adverse effects can outweigh the benefits of antiplatelet therapy. Striking a balance between safety and efficacy remains a major challenge. A consensus meeting of an expert panel composed of Taiwanese experts was held to provide recommendations for the management of adverse effects in patients with ACS receiving antiplatelet therapy. The common adverse effects of antiplatelet therapy include upper gastrointestinal bleeding, ecchymosis, hematuria, epistaxis and ticagrelor-related dyspnea. In this study, a literature review of these adverse events was performed and recommendations for the management were made. ? 2018, Republic of China Society of Cardiology. All rights reserved. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047087310&doi=10.6515%2fACS.201805_34%283%29.20180302A&partnerID=40&md5=f7b013cf736157f619dd0e521f4a89c4 https://scholars.lib.ntu.edu.tw/handle/123456789/533870 |
ISSN: | 1011-6842 | DOI: | 10.6515/ACS.201805_34(3).20180302A | SDG/關鍵字: | acetylsalicylic acid; antithrombocytic agent; clopidogrel; ticagrelor; acute coronary syndrome; acute heart infarction; bleeding; brain hemorrhage; cardiovascular disease; cerebrovascular accident; dual antiplatelet therapy; dyspnea; ecchymosis; epistaxis; gastrointestinal hemorrhage; hematuria; hemopericardium; hemoptysis; human; intraocular hemorrhage; perforation; randomized controlled trial (topic); retroperitoneal hemorrhage; Review; risk factor; Taiwan; treatment outcome; ulcer; upper gastrointestinal bleeding |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。